Stay updated on ARGX-113 in Myasthenia Gravis: Safety Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Safety Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study locations are reorganized to show individual sites by region (e.g., California, Florida, Ontario, Tokyo), and the HHS Vulnerability Disclosure footer was removed.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedMinor editorial notes were added indicating PubMed data sourcing for publications and updating the page revision to v3.3.2, which do not affect core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page no longer displays the government funding and operating status notice, which was previously shown to inform users about potential delays and updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedMinor UI and formatting adjustments observed; core study details and data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check92 days agoChange DetectedAdds a government-operating-status notice and upgrades the software version from v3.1.0 to v3.2.0; the legacy v3.1.0 is removed.SummaryDifference4%

- Check99 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0, indicating updated software/features.SummaryDifference0.1%

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Safety Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.